New pill ONO-1110 tested for fibromyalgia pain relief
NCT ID NCT06752590
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase IIa trial tests whether a new drug called ONO-1110 can safely reduce pain in people with fibromyalgia. About 160 Japanese adults will take either the drug or a placebo once daily for 8 weeks. Researchers will measure changes in pain scores and watch for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ONO-1110
What this could lead to
If it works, this could point toward a new daily pill to reduce fibromyalgia pain.
What could go wrong
This is an early Phase IIa trial with only 160 Japanese participants. The drug may not work better than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ai Sakura Clinic
Fukuoka, Fukuoka, Japan
-
Aichi Medical University Hospital
Nagakute, Aichi-ken, Japan
-
Fukuwa Clinic
Tokyo, Tokyo, Japan
-
Ginza Neurological Clinic
Tokyo, Tokyo, Japan
-
Hayaishi Hospital
Osaka, Osaka, Japan
-
Himenotomomi Clinic
Tokyo, Tokyo, Japan
-
Ikebukuro Internal Medicine
Tokyo, Tokyo, Japan
-
Japanese Red Cross Okayama Hospital
Okayama, Okayama-ken, Japan
-
Juntendo Tokyo Koto Geriatric Medical Center
Tokyo, Tokyo, Japan
-
Juntendo University Hospital
Tokyo, Tokyo, Japan
-
Juntendo University Nerima Hospital
Tokyo, Tokyo, Japan
-
Junwakai Memorial Hospital
Miyazaki, Miyazaki, Japan
-
Kimura Clinic
Nagoya, Aichi-ken, Japan
-
Kokorotoitami Clinic
Kawasaki, Kanagawa, Japan
-
Kyushu University Hospital
Fukuoka, Japan
-
Mayflower Hospital
Katō, Hyōgo, Japan
-
Medical Corporation Fujigaki Clinic
Ōita, Oita Prefecture, Japan
-
Miyashita Rheumatology Clinic
Ōmura, Nagasaki, Japan
-
Morimoto Clinic
Osaka, Osaka, Japan
-
National Hospital Organization Shimoshizu National Hospital
Yotsukaidō, Chiba, Japan
-
Nihonbashi Medical
Tokyo, Tokyo, Japan
-
Nishiogi Pain Clinic
Tokyo, Tokyo, Japan
-
Sanno Hospital
Tokyo, Tokyo, Japan
-
Sapporo City General Hospital
Sapporo, Hokkaido, Japan
-
Shirasawa Orthopedic Clinic
Morioka, Iwate, Japan
-
Shizuoka Rehab Pain Clinic
Shizuoka, Shizuoka, Japan
-
Tokyo-Eki Center-Building Clinic
Tokyo, Tokyo, Japan
-
Toyama University Hospital
Toyama, Toyama, Japan
-
Women's Clinic Luna
Yokohama, Kanagawa, Japan
-
Yakushinkai Healthcare Association Kandasudacho Dermatology
Tokyo, Japan